NCT02907242 is a NA clinical trial of Revealment in Stillbirth, sponsored by Hospital Clinic of Barcelona.

Who is sponsoring NCT02907242?

NCT02907242 is sponsored by Hospital Clinic of Barcelona.

What drugs are being tested in NCT02907242?

Interventions in NCT02907242: Revealment.

What condition does NCT02907242 study?

NCT02907242 studies Stillbirth.

Is NCT02907242 still recruiting?

NCT02907242 is currently completed. Last updated 18 April 2022.

Last reviewed 2022-04-18 · How we verify

NCT02907242

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Revealed Versus Concealed Cerebroplacental Ratio

Completed NA Last updated 18 April 2022

What this trial tests

NA trial testing Revealment in Stillbirth in 11,582 participants. Completed in 6 January 2022.

Timeline

4 May 2016

Primary endpoint
6 January 2022

6 January 2022

Quick facts

Lead sponsor	Hospital Clinic of Barcelona
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	11,582
Start date	4 May 2016
Primary completion	6 January 2022
Estimated completion	6 January 2022
Sites	9 locations across Chile, Israel, Poland, Mexico, Spain, Czechia

Drugs / interventions tested

Revealment

Conditions studied

Stillbirth — all drugs for Stillbirth →

Sponsor

Hospital Clinic of Barcelona

Who can join

Adults 18 to 50, female only, with Stillbirth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the role of an integrated strategy at selecting fetuses for delivery at term based on a combination of fetal biometry and cerebroplacental ratio (CPR) to reduce stillbirth rate and adverse perinatal outcome.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial.
Rial-Crestelo M, Lubusky M, Parra-Cordero M, Krofta L, et al · · 2024 · cited 30× · PMID 38219773 · DOI 10.1016/s0140-6736(23)02228-6
Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy (RATIO37): randomised controlled trial study protocol.
Figueras F, Gratacos E, Rial M, Gull I, et al · · 2017 · cited 27× · PMID 28619771 · DOI 10.1136/bmjopen-2016-014835

Verify or expand the search:

Other recruiting trials for Stillbirth

Currently open trials in the same condition.

NCT06125860 — BEP Targeting Strategies in Ethiopia · NA · recruiting
NCT06273007 — Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach · NA · recruiting
NCT04393259 — The Tommy's National Rainbow Clinic Study · recruiting
NCT03775954 — Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise · recruiting
NCT03662178 — Investigating the Structured Use of Ultrasound Scanning for Fetal Growth · recruiting

Other Hospital Clinic of Barcelona trials

Trials by the same sponsor.

NCT07509814 — Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery · NA · not yet recruiting
NCT07469358 — iCBT for Adolescents Obsessive-compulsive Dissorder · NA · active not recruiting
NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting
NCT07237867 — Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar T · NA · recruiting
NCT07163936 — Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Diseas · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02907242 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Clinic of Barcelona
Last refreshed: 18 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02907242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing